Post by Alira Health

What is the most complex challenge to address in cross-border clinical trials? We surveyed the audience of our recent webinar on this topic and found that 38% of attendees cited regulatory and ethical approval differences across countries as the top challenge. Check out more responses below. How can sponsors address these challenges? ▶️ Watch our latest on-demand webinar to explore practical approaches to designing and operationalizing patient-centric, feasible cross-border rare disease trials: https://lnkd.in/dzuFVquS